Related references
Note: Only part of the references are listed.Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC
Su-xiu Chen et al.
TUMOR BIOLOGY (2016)
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
Naomi B. Haas et al.
LANCET (2016)
Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy
A. Ravaud et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan et al.
SCIENCE (2016)
Cancer subtypes classification using long non-coding RNA
Ronan Flippot et al.
ONCOTARGET (2016)
A serum-circulating long noncoding RNA signature can discriminate between patients with clear cell renal cell carcinoma and healthy controls
Y. Wu et al.
ONCOGENESIS (2016)
Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma
Maximilian Seles et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Initial results from ASSURE (E2805): Adjuvant sorafenib or sunitinib for unfavorable renal carcinoma, an ECOG-ACRIN-led, NCTN phase III trial
Naomi B. Haas et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies
Brian Rini et al.
LANCET ONCOLOGY (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Characterization of long non-coding RNA transcriptome in clear-cell renal cell carcinoma by next-generation deep sequencing
Gabriel G. Malouf et al.
MOLECULAR ONCOLOGY (2015)
Identification of novel differentially expressed lncRNA and mRNA transcripts in clear cell renal cell carcinoma by expression profiling
Mario Deng et al.
GENOMICS DATA (2015)
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
B. Escudier et al.
ANNALS OF ONCOLOGY (2014)
Validation of housekeeping gene and impact on normalized gene expression in clear cell Renal Cell Carcinoma: critical reassessment of YBX3/ZONAB/CSDA expression
Sebastien Dupasquier et al.
BMC MOLECULAR BIOLOGY (2014)
Adjuvant Low-Dose Interleukin-2 (IL-2) Plus Interferon-α (IFN-α) in Operable Renal Cell Carcinoma (RCC): A Phase III, Randomized, Multicentre Trial of the Italian Oncology Group for Clinical Research (GOIRC)
Rodolfo Passalacqua et al.
JOURNAL OF IMMUNOTHERAPY (2014)
Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing
Marco Gerlinger et al.
NATURE GENETICS (2014)
Identification of a suitable qPCR reference gene in metastatic clear cell renal cell carcinoma
Piotr M. Wierzbicki et al.
TUMOR BIOLOGY (2014)
The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters
Brett Delahunt et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
PBRM1 and BAP1 as Novel Targets for Renal Cell Carcinoma
James Brugarolas
CANCER JOURNAL (2013)
Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton et al.
NATURE (2013)
Adjuvant Therapy in Renal Cell Carcinoma-Past, Present, and Future
Tobias Janowitz et al.
SEMINARS IN ONCOLOGY (2013)
The emerging role of targeted therapy in renal cell carcinoma (RCC): Is it time for a neoadjuvant or an adjuvant approach?
Alessandro Sciarra et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Molecular Markers of Injury in Kidney Biopsy Specimens of Patients with Lupus Nephritis
Heather N. Reich et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2011)
Adjuvant and Neoadjuvant Therapy in Renal Cell Carcinoma
Michel Choueiri et al.
CURRENT CLINICAL PHARMACOLOGY (2011)
Comparison of the UCLA Integrated Staging System and the Leibovich Score in Survival Prediction for Patients With Nonmetastatic Clear Cell Renal Cell Carcinoma
Min-Han Tan et al.
UROLOGY (2010)
Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor-Targeted Agents: Results From a Large, Multicenter Study
Daniel Y. C. Heng et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The role of VHL in clear-cell renal cell carcinoma and its relation to targeted therapy
Peter E. Clark
KIDNEY INTERNATIONAL (2009)
In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real-time PCR
Monika Jung et al.
BMC MOLECULAR BIOLOGY (2007)
Mononuclear cell infiltration in clear-cell renal cell carcinoma independently predicts patient survival
W. Scott Webster et al.
CANCER (2006)
Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma - A stratification tool for prospective clinical trials
BC Leibovich et al.
CANCER (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Share Paper
